Abstract
Purpose Bosentan, clazosentan, and tezosentan are three small-molecule endothelin receptor antagonists (ERAs), displacing endothelin-1 (ET-1) from its......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
